Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI • Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions • Judicial precedents and Supreme Court, High Court and other citations • Issue-wise legal analysis • Practical arguments and supporting content • Professionally structured draft ready for further review.
ITAT upholds weighted deduction for clinical trials abroad under sec 35(2AB) The ITAT ruled in favor of the assessee, dismissing the department's appeals in both AYs 2009-10 and 2010-11 regarding the allowance of weighted deduction ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
ITAT upholds weighted deduction for clinical trials abroad under sec 35(2AB)
The ITAT ruled in favor of the assessee, dismissing the department's appeals in both AYs 2009-10 and 2010-11 regarding the allowance of weighted deduction u/s 35(2AB) on clinical trials outside India. The ITAT upheld the CIT(A)'s order, citing that the expenditure on clinical trials outside India was part of scientific research expenditure and entitled to weighted deduction, as previously decided in the assessee's case for preceding assessment years.
Issues: Allowance of weighted deduction u/s 35(2AB) on clinical trials outside India.
Analysis: The appeals by the department were against the CIT(A)'s order regarding the allowance of the assessee's claim of weighted deduction u/s 35(2AB) on clinical trials outside India for AYs 2009-10 and 2010-11. The AO disallowed the claim as the expenditure on clinical trials outside India was not included by the prescribed authority in its report. However, the CIT(A) allowed the claim, citing that the expenditure on clinical drug trials is part of scientific research expenditure and entitled to weighted deduction. The CIT(A) also noted that a similar issue was decided in favor of the assessee by the ITAT in the assessee's own case for preceding assessment years.
Upon review, the ITAT found that the expenditure on clinical trials outside India was indeed mentioned in the report of the prescribed authority, contradicting the AO's reasoning for disallowance. The ITAT also referenced previous decisions by the Tribunal in the assessee's case, where it was held that the assessee is entitled to weighted deduction on such expenditure. As the CIT(A) had correctly applied the Tribunal's decision from the assessee's previous case, the ITAT upheld the CIT(A)'s order and dismissed the department's grounds in both assessment years.
Therefore, the ITAT ruled in favor of the assessee, dismissing the department's appeals in both AYs 2009-10 and 2010-11 regarding the allowance of weighted deduction u/s 35(2AB) on clinical trials outside India.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
AI Drafter ✕
TaxTMI 
